(Q34475723)

2 August 2017

1 reference

title

Mucosal defense and repair. Role of prostaglandins in the stomach and duodenum (English)

1 reference

2 August 2017

Cryer B

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Gastroenterology Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

30

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

877-94, v-vi

1 reference

Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study☆, ☆☆

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Exogenous prostaglandins and gastric secretion in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Aspirin-induced ultrastructural changes in human gastric mucosa: correlation with potential difference

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Expression and cellular localization of COX-1 and -2 in Helicobacter pylori gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Ketorolac and gastrointestinal ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Role of pepsin in the development of indomethacin‐induced antral ulceration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Age-associated decreases in prostaglandin contents in human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Effect of graded doses of intraluminal H+, prostaglandin E2, and inhibition of endogenous prostaglandin synthesis on proximal duodenal bicarbonate secretion in unanesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

The effect of prostaglandin E2 on duodenal ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

The incidence of duodenal and gastric ulcers in a large health maintenance organization.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Non-steroidal anti-inflammatory drugs and prostaglandin effects on pepsinogen secretion by dispersed human peptic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Bile-induced acute erosive gastritis. Its prevention by antacid, cholestyramine, and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

The effect of intravenous infusions of prostaglandins E-2 and F-2alpha on human gastric function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

NSAIDs, gastrointestinal injury, and cytoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Indomethacin inhibits duodenal mucosal bicarbonate secretion and endogenous prostaglandin E2 output in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970218-1

7 January 2021

10.1016/S0889-8553(05)70218-1

Identifiers

DOI

1 reference

2 August 2017

1 reference